Elevated B-cell activating factor BAFF, but not APRIL, correlates with CSF cerebellar autoantibodies in pediatric opsoclonus-myoclonus syndrome.

MLA

Fühlhuber, V., et al. “Elevated B-Cell Activating Factor BAFF, but Not APRIL, Correlates with CSF Cerebellar Autoantibodies in Pediatric Opsoclonus-Myoclonus Syndrome.” Journal of Neuroimmunology, vol. 210, no. 1–2, May 2009, pp. 87–91. EBSCOhost, https://doi.org/10.1016/j.jneuroim.2009.03.006.

APA

Fühlhuber, V., Bick, S., Kirsten, A., Hahn, A., Gerriets, T., Tschernatsch, M., Kaps, M., Preissner, K. T., Blaes, F., & Altenkämper, S. (2009). Elevated B-cell activating factor BAFF, but not APRIL, correlates with CSF cerebellar autoantibodies in pediatric opsoclonus-myoclonus syndrome. Journal of Neuroimmunology, 210(1–2), 87–91. https://doi.org/10.1016/j.jneuroim.2009.03.006

Chicago

Fühlhuber, V, S Bick, A Kirsten, A Hahn, T Gerriets, M Tschernatsch, M Kaps, K T Preissner, F Blaes, and S Altenkämper. 2009. “Elevated B-Cell Activating Factor BAFF, but Not APRIL, Correlates with CSF Cerebellar Autoantibodies in Pediatric Opsoclonus-Myoclonus Syndrome.” Journal of Neuroimmunology 210 (1–2): 87–91. doi:10.1016/j.jneuroim.2009.03.006.